Value Don't Lie

Value Don't Lie

Taro Pharmaceuticals ($TARO)

Dermatology drug maker at <2x earnings with huge net cash pile

Aug 07, 2022
∙ Paid
Share
$TARO 5yr chart

TARO manufactures generic pharmaceuticals sold in the US, Canada, and Internationally. Most of their sales come from dermatology / topical products (~60%). Some of you might be getting tired of the generics space, but not me!

This might be one of the cheapest securities I’ve ever seen.

This post is for paid subscribers

Already a paid subscriber? Sign in
© 2025 Value Don't Lie
Privacy ∙ Terms ∙ Collection notice
Start writingGet the app
Substack is the home for great culture